Health China
The 18th Annual EU Pharmaceutical Law Forum
Hotel Bloom
rue Royale 250
Brussels, Belgium
The 18th Annual EU Pharmaceutical Law Forum
Informa Life Sciences
Hotel Bloom

Schedule of Presentations:

Tuesday, May 12, 2009
08:15:00 Registration and Coffee
08:55:00 Chairman’s Introduction
09:00:00 The EU Pharma Sector Inquiry
09:30:00 Impact of the Sector Inquiry on Innovator and Generic Pharma Tony Woodgate
10:00:00 The Implications of the Sector Inquiry Tim Wilsdon
10:30:00 Morning Coffee
11:05:00 Life-Cycle Management & Settlement Strategies Post Sector Inquiry Marleen Van Kerkhove
11:40:00 Discussion on the Wider Implications of the Sector Inquiry Panel Session Gavin , Robert
12:00:00 Lunch
13:30:00 Market Definition and Dominance in Pharmaceutical Markets Matthijs , Visser
14:05:00 Catch Up On Competition Law from the Past 12 Months Cameron Firth
14:40:00 Parallel Trade after GSK Ian Forrester
15:15:00 Parallel Trade/IP – Repackaging Decisions and Implications Nick Beckett,
15:50:00 Afternoon Tea
16:20:00 New The Current European Patent System – A Patentee's Headache? Sally , Shorthose
16:55:00 Where do we stand on the Supplementary Protection Certificates front? Maria , Manley
17:30:00 End of Day One Networking Drinks
Wednesday, May 13, 2009
08:30:00 Morning Coffee
08:55:00 Chairman’s Introduction
09:00:00 Update on the Current Regulatory Framework Ian Dodds Smith
09:30:00 The New Regulatory Pharmaceutical Package Grant H Castle, Yuung Yuung Yap
10:30:00 Morning Coffee
11:10:00 Future Reform of the Clinical Trials Directive LINDA HORTON
11:40:00 Complying with the EU Data Privacy Directive in the Pharmaceutical Sector Tanguy Van Overstraeten
12:10:00 Update on the Paediatric Medicines Regulation Victoria Kitcatt
12:40:00 Lunch
14:00:00 The Advanced Therapies Regulation Ray Cresswell
15:00:00 Regulatory Requirements and Guidelines for Nanomedical Products Geert van Calster
15:30:00 Afternoon Tea
16:00:00 Judicial Review of Marketing Authorisations - Key Principles and Challenges Peter Bogaert
16:30:00 Legal and Regulatory Requirements for Combination & Borderline Products Elisabethann Wright
16:30:00 Health Technology Assessments - Where Does Europe Stand? Clare Sellars
17:00:00 Marketing and Promotion: Ensuring Compliance
17:05:00 End of Day Two
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.